{"schema_version":"1","generated_at":"2026-10-29T12:59:34.849Z","data_as_of":null,"url":"https://www.findmykol.com/kol/charles-lopez","json_url":"https://www.findmykol.com/kol/charles-lopez/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"charles-lopez","name":"Charles Lopez","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Portland","state":"OR","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1851473060"},"summary":"Charles Lopez is an Oncology physician. ClinicalTrials.gov lists 8 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":8,"shown":3,"withheld":5,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07089940","title":"OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma","phase":"EARLY_PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"OHSU Knight Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT07089940","trial_url":"https://www.findmykol.com/trial/NCT07089940"},{"nct":"NCT06630325","title":"A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"OHSU Knight Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT06630325","trial_url":"https://www.findmykol.com/trial/NCT06630325"},{"nct":"NCT06398587","title":"Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma","phase":"PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"OHSU Knight Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT06398587","trial_url":"https://www.findmykol.com/trial/NCT06398587"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Ipsen Biopharmaceuticals, Inc","program_year":2023,"amount_usd":7178.3,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851473060"},{"payer":"Genentech USA, Inc.","program_year":2023,"amount_usd":110.78,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851473060"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1851473060","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":54.5,"classes_total":4,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":20.3,"drugs":[{"name":"Loperamide","share_pct":100}],"max_beneficiaries":23},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":19.3,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":23}]},{"area":"Sensory organs","share_pct":20.8,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":20.8,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":16}]},{"area":"Nervous system","share_pct":18.3,"classes_total":2,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":12.9,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":18},{"class":"Opioid Agonist","setting":"prescribed","share_pct":5.4,"drugs":[{"name":"Oxycodone Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":95.8,"facility_pct":4.2},"source":"medicare"},"funding":{"award_count":2,"fiscal_years":{"first":2001,"last":2008},"rows_total":9,"shown":3,"withheld":6,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01CA104997","title":"Mechanisms linking ASPP2 to the Rb/E2F and p53 pathways","fiscal_year":2008,"amount_usd":"301542","organization":"OREGON HEALTH & SCIENCE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01CA104997"},{"project":"R01CA104997","title":"Mechanisms linking ASPP2 to the Rb/E2F and p53 pathways","fiscal_year":2007,"amount_usd":"301542","organization":"OREGON HEALTH & SCIENCE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01CA104997"},{"project":"R01CA104997","title":"Mechanisms linking ASPP2 to the Rb/E2F and p53 pathways","fiscal_year":2006,"amount_usd":"310423","organization":"OREGON HEALTH & SCIENCE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R01CA104997"}],"source":"grants"},"contact":{"address_1":"3181 SW SAM JACKSON PARK RD","city":"Portland","state":"OR","zip":"972393011","phone":"503-494-6594","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1851473060","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":5,"funding":6}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2007-07-26","collected_at":"2026-10-27T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}